Google
BRKR — BRUKER CORPORATION (Healthcare >> Medical Devices)
BRKR FAQ
What is BRKR's P/E ratio?
BRUKER CORPORATION (BRKR) currently trades at a P/E ratio of 181.75.
What is BRKR's ROE?
BRUKER CORPORATION reports a Return on Equity (ROE) of -0.47%.
What is BRKR's dividend yield?
BRUKER CORPORATION offers a dividend yield of 0.34%.
What is BRKR's Deepscope Quality Score?
Deepscope rates BRKR's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy BRKR?
Deepscope's AI Timing Score for BRKR is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does BRKR belong to?
BRUKER CORPORATION is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 62.70
Price
5.39
(9.40%)
Day Change
|
|
|---|
BRKR, the overall quality is not good ( Quality = 31) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 62.70 |
| PBV / Sector |
3.49 / 7.31
|
| Earning Per Share | -0.08 |
| PE / Sector |
181.75 / 28.52
|
| PEG or PE/Growth / Sector |
-4.03 / 0.39
|
| Average 1M Daily Value |
143.69 M
GREAT
|
| Average 1W Daily Value |
246.52 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
52% |
| Return to Investors |
|
41% |
| Registration Details |
| Analyze Date | 2026-06-04 09:23:40 |
| Symbol | BRKR |
| Name | BRUKER CORPORATION |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 152.23 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 8,724.05 / 17,902.07 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 40 Manning Road, Billerica, MA, United States, 01821
Phone: 978 663 3660
Website: https://www.bruker.com
Employees: 11,085
Sector: Healthcare >> Medical Devices
Description: Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
